Does METFORMIN\SITAGLIPTIN Cause Product dose omission issue? 452 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 452 reports of Product dose omission issue have been filed in association with METFORMIN\SITAGLIPTIN. This represents 5.1% of all adverse event reports for METFORMIN\SITAGLIPTIN.
452
Reports of Product dose omission issue with METFORMIN\SITAGLIPTIN
5.1%
of all METFORMIN\SITAGLIPTIN reports
0
Deaths
21
Hospitalizations
How Dangerous Is Product dose omission issue From METFORMIN\SITAGLIPTIN?
Of the 452 reports, 21 (4.6%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METFORMIN\SITAGLIPTIN. However, 452 reports have been filed with the FAERS database.
What Other Side Effects Does METFORMIN\SITAGLIPTIN Cause?
Blood glucose increased (709)
Acute kidney injury (616)
Lactic acidosis (557)
No adverse event (539)
Diarrhoea (513)
Inappropriate schedule of drug administration (469)
Pancreatic carcinoma (431)
Drug ineffective (384)
Nausea (378)
Diabetes mellitus inadequate control (364)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which METFORMIN\SITAGLIPTIN Alternatives Have Lower Product dose omission issue Risk?
METFORMIN\SITAGLIPTIN vs METFORMIN\VILDAGLIPTIN
METFORMIN\SITAGLIPTIN vs METHADONE
METFORMIN\SITAGLIPTIN vs METHAMPHETAMINE
METFORMIN\SITAGLIPTIN vs METHENAMINE HIPPURATE
METFORMIN\SITAGLIPTIN vs METHIMAZOLE